However, only the models whose mutations are most frequent in sporadic CRC in humans (APC> 70%, p53> 60% and K-ras> 40%) and in hereditary familial adenomatous polyposis(APC) and hereditary nonpolyposis colorectal cancer(MMR)11 will be described next. This evidence concerns the gene KRAS and Familial adenomatous polyposis.